663 research outputs found

    Inferring epigenetic and transcriptional regulation during blood cell development with a mixture of sparse linear models

    Get PDF
    Motivation: Blood cell development is thought to be controlled by a circuit of transcription factors (TFs) and chromatin modifications that determine the cell fate through activating cell type-specific expression programs. To shed light on the interplay between histone marks and TFs during blood cell development, we model gene expression from regulatory signals by means of combinations of sparse linear regression models. Results: The mixture of sparse linear regression models was able to improve the gene expression prediction in relation to the use of a single linear model. Moreover, it performed an efficient selection of regulatory signals even when analyzing all TFs with known motifs (>600). The method identified interesting roles for histone modifications and a selection of TFs related to blood development and chromatin remodelling. Availability: The method and datasets are available from http://www.cin.ufpe.br/~igcf/SparseMix. Contact: [email protected] Supplementary information:Supplementary data are available at Bioinformatics online

    Computational approaches for single-cell omics and multi-omics data

    Get PDF
    Single-cell omics and multi-omics technologies have enabled the study of cellular heterogeneity with unprecedented resolution and the discovery of new cell types. The core of identifying heterogeneous cell types, both existing and novel ones, relies on efficient computational approaches, including especially cluster analysis. Additionally, gene regulatory network analysis and various integrative approaches are needed to combine data across studies and different multi-omics layers. This thesis comprehensively compared Bayesian clustering models for single-cell RNAsequencing (scRNA-seq) data and selected integrative approaches were used to study the cell-type specific gene regulation of uterus. Additionally, single-cell multi-omics data integration approaches for cell heterogeneity analysis were investigated. Article I investigated analytical approaches for cluster analysis in scRNA-seq data, particularly, latent Dirichlet allocation (LDA) and hierarchical Dirichlet process (HDP) models. The comparison of LDA and HDP together with the existing state-of-art methods revealed that topic modeling-based models can be useful in scRNA-seq cluster analysis. Evaluation of the cluster qualities for LDA and HDP with intrinsic and extrinsic cluster quality metrics indicated that the clustering performance of these methods is dataset dependent. Article II and Article III focused on cell-type specific integrative analysis of uterine or decidual stromal (dS) and natural killer (dNK) cells that are important for successful pregnancy. Article II integrated the existing preeclampsia RNA-seq studies of the decidua together with recent scRNA-seq datasets in order to investigate cell-type-specific contributions of early onset preeclampsia (EOP) and late onset preeclampsia (LOP). It was discovered that the dS marker genes were enriched for LOP downregulated genes and the dNK marker genes were enriched for upregulated EOP genes. Article III presented a gene regulatory network analysis for the subpopulations of dS and dNK cells. This study identified novel subpopulation specific transcription factors that promote decidualization of stromal cells and dNK mediated maternal immunotolerance. In Article IV, different strategies and methodological frameworks for data integration in single-cell multi-omics data analysis were reviewed in detail. Data integration methods were grouped into early, late and intermediate data integration strategies. The specific stage and order of data integration can have substantial effect on the results of the integrative analysis. The central details of the approaches were presented, and potential future directions were discussed.  Laskennallisia menetelmiä yksisolusekvensointi- ja multiomiikkatulosten analyyseihin Yksisolusekvensointitekniikat mahdollistavat solujen heterogeenisyyden tutkimuksen ennennäkemättömällä resoluutiolla ja uusien solutyyppien löytämisen. Solutyyppien tunnistamisessa keskeisessä roolissa on ryhmittely eli klusterointianalyysi. Myös geenien säätelyverkostojen sekä eri molekyylidatatasojen yhdistäminen on keskeistä analyysissä. Väitöskirjassa verrataan bayesilaisia klusterointimenetelmiä ja yhdistetään eri menetelmillä kerättyjä tietoja kohdun solutyyppispesifisessä geeninsäätelyanalyysissä. Lisäksi yksisolutiedon integraatiomenetelmiä selvitetään kattavasti. Julkaisu I keskittyy analyyttisten menetelmien, erityisesti latenttiin Dirichletallokaatioon (LDA) ja hierarkkiseen Dirichlet-prosessiin (HDP) perustuvien mallien tutkimiseen yksisoludatan klusterianalyysissä. Kattava vertailu näiden kahden mallin sekä olemassa olevien menetelmien kanssa paljasti, että aihemallinnuspohjaiset menetelmät voivat olla hyödyllisiä yksisoludatan klusterianalyysissä. Menetelmien suorituskyky riippui myös kunkin analysoitavan datasetin ominaisuuksista. Julkaisuissa II ja III keskitytään naisen lisääntymisterveydelle tärkeiden kohdun stroomasolujen ja NK-immuunisolujen solutyyppispesifiseen analyysiin. Artikkelissa II yhdistettiin olemassa olevia tuloksia pre-eklampsiasta viimeisimpiin yksisolusekvensointituloksiin ja löydettiin varhain alkavan pre-eklampsian (EOP) ja myöhään alkavan pre-eklampsian (LOP) solutyyppispesifisiä vaikutuksia. Havaittiin, että erilaistuneen strooman markkerigeenien ilmentyminen vähentyi LOP:ssa ja NK-markkerigeenien ilmentyminen lisääntyi EOP:ssa. Julkaisu III analysoi strooman ja NK-solujen alapopulaatiospesifisiä geeninsäätelyverkostoja ja niiden transkriptiofaktoreita. Tutkimus tunnisti uusia alapopulaatiospesifisiä säätelijöitä, jotka edistävät strooman erilaistumista ja NK-soluvälitteistä immunotoleranssia Julkaisu IV tarkastelee yksityiskohtaisesti strategioita ja menetelmiä erilaisten yksisoludatatasojen (multi-omiikka) integroimiseksi. Integrointimenetelmät ryhmiteltiin varhaisen, myöhäisen ja välivaiheen strategioihin ja kunkin lähestymistavan menetelmiä esiteltiin tarkemmin. Lisäksi keskusteltiin mahdollisista tulevaisuuden suunnista

    Unveiling gene expression histonic regulative patterns by hyperplanes clustering

    Get PDF
    In targeted cancer therapy, great relevance is assumed by data-driven investigations on the fundamental mechanisms by which epigenetic modifications cooperate to regulate the transcriptional status of genes. At the high resolution level of genome-wide studies, only general, mean regulative motifs are drawn, with possible multi-functional co-regulative roles remaining concealed. In order to retrieve sharper and more reliable regulative patterns, in this work we propose the application of Kplane regression to partition the set of protein coding genes into clusters with shared regulative mechanisms. Completely data-driven, the approach has computed clusters of genes significantly better fitted by specific linear models than by single regression, and characterized by distinct histonic input patterns and mean measured expression values

    Revealing the vectors of cellular identity with single-cell genomics

    Get PDF
    Single-cell genomics has now made it possible to create a comprehensive atlas of human cells. At the same time, it has reopened definitions of a cell's identity and of the ways in which identity is regulated by the cell's molecular circuitry. Emerging computational analysis methods, especially in single-cell RNA sequencing (scRNA-seq), have already begun to reveal, in a data-driven way, the diverse simultaneous facets of a cell's identity, from discrete cell types to continuous dynamic transitions and spatial locations. These developments will eventually allow a cell to be represented as a superposition of 'basis vectors', each determining a different (but possibly dependent) aspect of cellular organization and function. However, computational methods must also overcome considerable challenges-from handling technical noise and data scale to forming new abstractions of biology. As the scale of single-cell experiments continues to increase, new computational approaches will be essential for constructing and characterizing a reference map of cell identities.National Institutes of Health (U.S.) (grant P50 HG006193)BRAIN Initiative (grant U01 MH105979)National Institutes of Health (U.S.) (BRAIN grant 1U01MH105960-01)National Cancer Institute (U.S.) (grant 1U24CA180922)National Institute of Allergy and Infectious Diseases (U.S.) (grant 1U24AI118672-01

    Statistical Methods in Integrative Genomics

    Get PDF
    Statistical methods in integrative genomics aim to answer important biology questions by jointly analyzing multiple types of genomic data (vertical integration) or aggregating the same type of data across multiple studies (horizontal integration). In this article, we introduce different types of genomic data and data resources, and then review statistical methods of integrative genomics, with emphasis on the motivation and rationale of these methods. We conclude with some summary points and future research directions

    INTEGRATIVE ANALYSIS OF OMICS DATA IN ADULT GLIOMA AND OTHER TCGA CANCERS TO GUIDE PRECISION MEDICINE

    Get PDF
    Transcriptomic profiling and gene expression signatures have been widely applied as effective approaches for enhancing the molecular classification, diagnosis, prognosis or prediction of therapeutic response towards personalized therapy for cancer patients. Thanks to modern genome-wide profiling technology, scientists are able to build engines leveraging massive genomic variations and integrating with clinical data to identify “at risk” individuals for the sake of prevention, diagnosis and therapeutic interventions. In my graduate work for my Ph.D. thesis, I have investigated genomic sequencing data mining to comprehensively characterise molecular classifications and aberrant genomic events associated with clinical prognosis and treatment response, through applying high-dimensional omics genomic data to promote the understanding of gene signatures and somatic molecular alterations contributing to cancer progression and clinical outcomes. Following this motivation, my dissertation has been focused on the following three topics in translational genomics. 1) Characterization of transcriptomic plasticity and its association with the tumor microenvironment in glioblastoma (GBM). I have integrated transcriptomic, genomic, protein and clinical data to increase the accuracy of GBM classification, and identify the association between the GBM mesenchymal subtype and reduced tumorpurity, accompanied with increased presence of tumor-associated microglia. Then I have tackled the sole source of microglial as intrinsic tumor bulk but not their corresponding neurosphere cells through both transcriptional and protein level analysis using a panel of sphere-forming glioma cultures and their parent GBM samples.FurthermoreI have demonstrated my hypothesis through longitudinal analysis of paired primary and recurrent GBM samples that the phenotypic alterations of GBM subtypes are not due to intrinsic proneural-to-mesenchymal transition in tumor cells, rather it is intertwined with increased level of microglia upon disease recurrence. Collectively I have elucidated the critical role of tumor microenvironment (Microglia and macrophages from central nervous system) contributing to the intra-tumor heterogeneity and accurate classification of GBM patients based on transcriptomic profiling, which will not only significantly impact on clinical perspective but also pave the way for preclinical cancer research. 2) Identification of prognostic gene signatures that stratify adult diffuse glioma patientsharboring1p/19q co-deletions. I have compared multiple statistical methods and derived a gene signature significantly associated with survival by applying a machine learning algorithm. Then I have identified inflammatory response and acetylation activity that associated with malignant progression of 1p/19q co-deleted glioma. In addition, I showed this signature translates to other types of adult diffuse glioma, suggesting its universality in the pathobiology of other subset gliomas. My efforts on integrative data analysis of this highly curated data set usingoptimizedstatistical models will reflect the pending update to WHO classification system oftumorsin the central nervous system (CNS). 3) Comprehensive characterization of somatic fusion transcripts in Pan-Cancers. I have identified a panel of novel fusion transcripts across all of TCGA cancer types through transcriptomic profiling. Then I have predicted fusion proteins with kinase activity and hub function of pathway network based on the annotation of genetically mobile domains and functional domain architectures. I have evaluated a panel of in -frame gene fusions as potential driver mutations based on network fusion centrality hypothesis. I have also characterised the emerging complexity of genetic architecture in fusion transcripts through integrating genomic structure and somatic variants and delineating the distinct genomic patterns of fusion events across different cancer types. Overall my exploration of the pathogenetic impact and clinical relevance of candidate gene fusions have provided fundamental insights into the management of a subset of cancer patients by predicting the oncogenic signalling and specific drug targets encoded by these fusion genes. Taken together, the translational genomic research I have conducted during my Ph.D. study will shed new light on precision medicine and contribute to the cancer research community. The novel classification concept, gene signature and fusion transcripts I have identified will address several hotly debated issues in translational genomics, such as complex interactions between tumor bulks and their adjacent microenvironments, prognostic markers for clinical diagnostics and personalized therapy, distinct patterns of genomic structure alterations and oncogenic events in different cancer types, therefore facilitating our understanding of genomic alterations and moving us towards the development of precision medicine

    Computational solutions for addressing heterogeneity in DNA methylation data

    Get PDF
    DNA methylation, a reversible epigenetic modification, has been implicated with various bi- ological processes including gene regulation. Due to the multitude of datasets available, it is a premier candidate for computational tool development, especially for investigating hetero- geneity within and across samples. We differentiate between three levels of heterogeneity in DNA methylation data: between-group, between-sample, and within-sample heterogeneity. Here, we separately address these three levels and present new computational approaches to quantify and systematically investigate heterogeneity. Epigenome-wide association studies relate a DNA methylation aberration to a phenotype and therefore address between-group heterogeneity. To facilitate such studies, which necessar- ily include data processing, exploratory data analysis, and differential analysis of DNA methy- lation, we extended the R-package RnBeads. We implemented novel methods for calculating the epigenetic age of individuals, novel imputation methods, and differential variability analysis. A use-case of the new features is presented using samples from Ewing sarcoma patients. As an important driver of epigenetic differences between phenotypes, we systematically investigated associations between donor genotypes and DNA methylation states in methylation quantitative trait loci (methQTL). To that end, we developed a novel computational framework –MAGAR– for determining statistically significant associations between genetic and epigenetic variations. We applied the new pipeline to samples obtained from sorted blood cells and complex bowel tissues of healthy individuals and found that tissue-specific and common methQTLs have dis- tinct genomic locations and biological properties. To investigate cell-type-specific DNA methylation profiles, which are the main drivers of within-group heterogeneity, computational deconvolution methods can be used to dissect DNA methylation patterns into latent methylation components. Deconvolution methods require pro- files of high technical quality and the identified components need to be biologically interpreted. We developed a computational pipeline to perform deconvolution of complex DNA methyla- tion data, which implements crucial data processing steps and facilitates result interpretation. We applied the protocol to lung adenocarcinoma samples and found indications of tumor in- filtration by immune cells and associations of the detected components with patient survival. Within-sample heterogeneity (WSH), i.e., heterogeneous DNA methylation patterns at a ge- nomic locus within a biological sample, is often neglected in epigenomic studies. We present the first systematic benchmark of scores quantifying WSH genome-wide using simulated and experimental data. Additionally, we created two novel scores that quantify DNA methyla- tion heterogeneity at single CpG resolution with improved robustness toward technical biases. WSH scores describe different types of WSH in simulated data, quantify differential hetero- geneity, and serve as a reliable estimator of tumor purity. Due to the broad availability of DNA methylation data, the levels of heterogeneity in DNA methylation data can be comprehensively investigated. We contribute novel computational frameworks for analyzing DNA methylation data with respect to different levels of hetero- geneity. We envision that this toolbox will be indispensible for understanding the functional implications of DNA methylation patterns in health and disease.DNA Methylierung ist eine reversible, epigenetische Modifikation, die mit verschiedenen biologischen Prozessen wie beispielsweise der Genregulation in Verbindung steht. Eine Vielzahl von DNA Methylierungsdatensätzen bildet die perfekte Grundlage zur Entwicklung von Softwareanwendungen, insbesondere um Heterogenität innerhalb und zwischen Proben zu beschreiben. Wir unterscheiden drei Ebenen von Heterogenität in DNA Methylierungsdaten: zwischen Gruppen, zwischen Proben und innerhalb einer Probe. Hier betrachten wir die drei Ebenen von Heterogenität in DNA Methylierungsdaten unabhängig voneinander und präsentieren neue Ansätze um die Heterogenität zu beschreiben und zu quantifizieren. Epigenomweite Assoziationsstudien verknüpfen eine DNA Methylierungsveränderung mit einem Phänotypen und beschreiben Heterogenität zwischen Gruppen. Um solche Studien, welche Datenprozessierung, sowie exploratorische und differentielle Datenanalyse beinhalten, zu vereinfachen haben wir die R-basierte Softwareanwendung RnBeads erweitert. Die Erweiterungen beinhalten neue Methoden, um das epigenetische Alter vorherzusagen, neue Schätzungsmethoden für fehlende Datenpunkte und eine differentielle Variabilitätsanalyse. Die Analyse von Ewing-Sarkom Patientendaten wurde als Anwendungsbeispiel für die neu entwickelten Methoden gewählt. Wir untersuchten Assoziationen zwischen Genotypen und DNA Methylierung von einzelnen CpGs, um sogenannte methylation quantitative trait loci (methQTL) zu definieren. Diese stellen einen wichtiger Faktor dar, der epigenetische Unterschiede zwischen Gruppen induziert. Hierzu entwickelten wir ein neues Softwarepaket (MAGAR), um statistisch signifikante Assoziationen zwischen genetischer und epigenetischer Variation zu identifizieren. Wir wendeten diese Pipeline auf Blutzelltypen und komplexe Biopsien von gesunden Individuen an und konnten gemeinsame und gewebespezifische methQTLs in verschiedenen Bereichen des Genoms lokalisieren, die mit unterschiedlichen biologischen Eigenschaften verknüpft sind. Die Hauptursache für Heterogenität innerhalb einer Gruppe sind zelltypspezifische DNA Methylierungsmuster. Um diese genauer zu untersuchen kann Dekonvolutionssoftware die DNA Methylierungsmatrix in unabhängige Variationskomponenten zerlegen. Dekonvolutionsmethoden auf Basis von DNA Methylierung benötigen technisch hochwertige Profile und die identifizierten Komponenten müssen biologisch interpretiert werden. In dieser Arbeit entwickelten wir eine computerbasierte Pipeline zur Durchführung von Dekonvolutionsexperimenten, welche die Datenprozessierung und Interpretation der Resultate beinhaltet. Wir wendeten das entwickelte Protokoll auf Lungenadenokarzinome an und fanden Anzeichen für eine Tumorinfiltration durch Immunzellen, sowie Verbindungen zum Überleben der Patienten. Heterogenität innerhalb einer Probe (within-sample heterogeneity, WSH), d.h. heterogene Methylierungsmuster innerhalb einer Probe an einer genomischen Position, wird in epigenomischen Studien meist vernachlässigt. Wir präsentieren den ersten Vergleich verschiedener, genomweiter WSH Maße auf simulierten und experimentellen Daten. Zusätzlich entwickelten wir zwei neue Maße um WSH für einzelne CpGs zu berechnen, welche eine verbesserte Robustheit gegenüber technischen Faktoren aufweisen. WSH Maße beschreiben verschiedene Arten von WSH, quantifizieren differentielle Heterogenität und sagen Tumorreinheit vorher. Aufgrund der breiten Verfügbarkeit von DNA Methylierungsdaten können die Ebenen der Heterogenität ganzheitlich beschrieben werden. In dieser Arbeit präsentieren wir neue Softwarelösungen zur Analyse von DNA Methylierungsdaten in Bezug auf die verschiedenen Ebenen der Heterogenität. Wir sind davon überzeugt, dass die vorgestellten Softwarewerkzeuge unverzichtbar für das Verständnis von DNA Methylierung im kranken und gesunden Stadium sein werden
    corecore